Novo Nordisk Named 'Best Place to Work in New Jersey'
April 30 2009 - 7:00AM
PR Newswire (US)
Renowned employer of choice takes top spot for third time; second
award in 2009 PRINCETON, N.J., April 30 /PRNewswire-FirstCall/ --
Novo Nordisk, a world leader in diabetes care, has been recognized
as the "Best Place to Work in New Jersey" by NJBiz, the state's
largest weekly business newspaper. This is the third time in five
years the company has achieved this honor. Earlier this year, the
company was recognized as one of FORTUNE's "100 Best Companies to
Work For." "This award is a tribute to our unique company culture
and our commitment to inspire and engage our employees through our
company's vision of defeating diabetes," said Jerzy Gruhn,
president of Novo Nordisk Inc. "You can attract top talent with
compensation and benefits, but you retain them through a sense of
purpose and a common passion. Ours is working for the people who
need our therapies." The ranking is based on an independent
assessment of policies, practices and demographics as well as a
comprehensive employee survey. "Our continued presence and high
ranking on the list demonstrates the value we place on the personal
and professional satisfaction and growth of our employees," said
Jeff Frazier, vice president of human resources. "To maintain and
extend Novo Nordisk's competitive advantage, we apply innovative
thinking to better our organizational structure, provide
responsible employee health incentives and offer exciting
developmental opportunities that resonate with our employees."
Among the company attributes considered in Novo Nordisk's
recognition is the company's creative benefits program for
employees in a variety of areas. This year, Novo Nordisk developed
and implemented College Coach, a program that assists parents with
preparing for college savings. Other company efforts include
concierge services, backup care for children and dependent adults,
and a generous 401k plan: Novo Nordisk contributes 8 percent to an
employee's 401k even if that individual does not participate. In
addition to finding professional gratification, Novo Nordisk
employees report an emotional connection with the company's goals.
In the most recent annual survey employees rated an average score
of 4.68 out of a possible five to indicate their level of agreement
with statements including "Novo Nordisk is leading the fight
against diabetes," "Novo Nordisk's results within the social and
environmental area are important to the future of the company," and
"I am proud of our products." The "Best Place to Work in New
Jersey" award is part of the weekly publication's annual survey to
honor the companies in New Jersey that show a dedication to their
employees' growth and quality of life, which was published in a
supplement to the April 27 issue and online at
http://www.njbiz.com/. About Novo Nordisk Novo Nordisk is a
healthcare company with an 86-year history of innovation and
achievement in diabetes care. The company has the broadest diabetes
product portfolio in the industry, including the most advanced
products within the area of insulin delivery systems. In addition
to diabetes care, Novo Nordisk has a leading position within areas
such as hemostasis management, growth hormone therapy, and hormone
therapy for women. Novo Nordisk's business is driven by the Triple
Bottom Line: a commitment to social responsibility to employees and
customers, environmental soundness and economic success. With
headquarters in Denmark, Novo Nordisk employs more than 27,000
employees in 81 countries, and markets its products in 179
countries. Novo Nordisk's B shares are listed on the stock
exchanges in Copenhagen and London. Its ADRs are listed on the New
York Stock Exchange under the symbol 'NVO'. For global information,
visit novonordisk.com; for United States information, visit
novonordisk-us.com.
http://www.newscom.com/cgi-bin/prnh/20020404/NVOLOGODATASOURCE:
Novo Nordisk CONTACT: Sean Clements, Media, +1-609-514-8316, , or
Hans Rommer, Investors, +1-609-919-7937, Web Site:
http://www.novonordisk.com/
Copyright